Companies ›Consumer Non Cyclicals ›MLFMV.EUL

MLFMV.EUL — — Drug Retailers

Mlfmv.Eul

$3,40

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

3,9 %

ROE

7,4 %

Net margin

1,3 %

Debt / equity

1,66

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

MLFMV.EUL operates in the drug retailing sector, generating revenue primarily through the sale of pharmaceuticals and related health care products.

Business. MLFMV.EUL operates in the drug retailing sector, generating revenue primarily through the sale of pharmaceuticals and related health care products.

Classification92 %

SectorConsumer Non-Cyclicals

Business sectorFood & Drug Retailing

IndustryDrug Retailers

ActivityFood & Drug Retailing

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability→

7,4 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning MLFMV.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to MLFMV.EUL. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

MLFMV.EUL operates in the drug retailing sector, generating revenue primarily through the sale of pharmaceuticals and related health care products.

Classification92 %

SectorConsumer Non-Cyclicals

Business sectorFood & Drug Retailing

IndustryDrug Retailers

ActivityFood & Drug Retailing

AI synthesis

GENERATED

MLFMV.EUL has a debt-to-equity ratio of 1.66, indicating a relatively high level of leverage, and a current ratio of 0.95, suggesting limited short-term liquidity. The company's free cash flow is modest at 2.26 million EUR, and its operating cash flow is 24.39 million EUR, which is insufficient to cover its long-term debt of 248.47 million EUR.

The company's profitability is modest, with a return on equity of 7.44% and a return on assets of 1.7%. These figures are below the typical thresholds for strong performance in the drug retailing industry, indicating that the company is not generating robust returns relative to its equity and asset base.

MLFMV.EUL's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher operational and market risks.

The company's growth trajectory is constrained, with no significant revenue growth reported in the latest financial period. The outlook for the current fiscal year does not indicate a substantial increase in revenue, and the next fiscal year is expected to show only marginal improvement.

The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could limit its ability to fund operations or invest in growth opportunities without external financing.

Recent filings and transcripts do not indicate any major strategic shifts or significant events that would impact the company's financial performance in the near term. The company appears to be maintaining a stable but conservative financial strategy.

Key takeaways

MLFMV.EUL is highly leveraged with a debt-to-equity ratio of 1.66, which could constrain its financial flexibility.
The company's return on equity and return on assets are below typical industry benchmarks, indicating suboptimal profitability.
Revenue is concentrated in a single segment, increasing exposure to market-specific risks.
The company's liquidity position is weak, with a current ratio of 0.95 and negative net cash after debt.
No significant growth is expected in the near term, with only marginal revenue improvements projected.

Bull / Bear case

analysis pipeline

— missing data

In focus — financials by report

Valuation

Market price

$3,40

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

$150.0M

Net cashⓘ

-$224.5M

Current ratioⓘ

0.9

Debt / equityⓘ

1.7

ROAⓘ

1.7%

ROEⓘ

7.4%

Cash conversionⓘ

219.0%

CapEx / revenueⓘ

-2.5%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin3,9 %Above median

Net Margin1,3 %Above median

ROE7,4 %Above median

Capex / Rev-2,5 %Below median

D/E1,66Bottom quartile

Cash Conv2,19Above median

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

MLFMV.EUL Market data — financials · 2026-05-28

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

MLFMV.EULCanonical

— · USD

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread